Ann: Appendix 3B - Grant of Employee Peformance Rights, page-2

This makes me physically sick.

Lets (a) give Gary about $325,000 worth of free money, all he has to do is sit at his desk and do nothing for two years and (b) not give any hope to shareholders as to how they will ever see a return on their investment.

Let me ask the question directly to anyone at PXS who might be reading:

"On the assumption that some of your drug developments are successful enough to show a financial return to PXS and its management team, what are your plans for distributing this revenue stream to shareholders?"